3 Stocks Pushing The Health Services Industry Higher

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 9 points (-0.1%) at 14,437 as of Tuesday, March 12, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,094 issues advancing vs. 1,829 declining with 130 unchanged.

The Health Services industry currently is unchanged today versus the S&P 500, which is down 0.3%. Top gainers within the industry include Life Technologies ( LIFE), up 2.3%, Aetna ( AET), up 1.5%, UnitedHealth Group ( UNH), up 1.2%, Smith & Nephew ( SNN), up 0.8% and WellPoint ( WLP), up 0.5%. On the negative front, top decliners within the industry include Intuitive Surgical ( ISRG), down 1.0%, Baxter International ( BAX), down 0.8% and Edwards Life ( EW), down 0.5%.

TheStreet Ratings group would like to highlight 3 stocks pushing the industry higher today:

3. DexCom ( DXCM) is one of the companies pushing the Health Services industry higher today. As of noon trading, DexCom is up $0.97 (6.2%) to $16.54 on heavy volume Thus far, 448,186 shares of DexCom exchanged hands as compared to its average daily volume of 373,400 shares. The stock has ranged in price between $15.78-$16.63 after having opened the day at $15.81 as compared to the previous trading day's close of $15.57.

DexCom, Inc., a medical device company, engages in the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes, and for use by healthcare providers in the hospital for the treatment of diabetic and non-diabetic patients. DexCom has a market cap of $1.1 billion and is part of the health care sector. Shares are up 17.4% year to date as of the close of trading on Monday. Currently there are 8 analysts that rate DexCom a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates DexCom as a sell. Among the areas we feel are negative, one of the most important has been an overall disappointing return on equity. Get the full DexCom Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you liked this article you might like

Apple Watch Is on Its Way to Becoming a $6 Billion Business, but Is That Really Enough?

DexCom Shares Rise After FDA Approves G5 Mobile App for Android Devices

Apple Watch Appears on Its Way to Becoming a $6 Billion Business

DexCom Stock Surging on Apple Watch Partnership

Markets Down? Get Used to It: Cramer's 'Mad Money' Recap (Wednesday 5/17/17)